This document is a position statement from the Society for Cardiovascular Magnetic Resonance (SCMR) on recommendations for clinical utilization of cardiovascular magnetic resonance (CMR) in women with cardiovascular disease. The document was prepared by the SCMR Consensus Group on CMR Imaging for Female Patients with Cardiovascular Disease and endorsed by the SCMR Publications Committee and SCMR Executive Committee. The goals of this document are to (1) guide the informed selection of cardiovascular imaging methods, (2) inform clinical decision-making, (3) educate stakeholders on the advantages of CMR in specific clinical scenarios, and (4) empower patients with clinical evidence to participate in their clinical care. The statements of clinical utility presented in the current document pertain to the following clinical scenarios: acute coronary syndrome, stable ischemic heart disease, peripartum cardiomyopathy, cancer therapy-related cardiac dysfunction, aortic syndrome and congenital heart disease in pregnancy, bicuspid aortic valve and aortopathies, systemic rheumatic diseases and collagen vascular disorders, and cardiomyopathy-causing mutations. The authors cite published evidence when available and provide expert consensus otherwise. Most of the evidence available pertains to translational studies involving subjects of both sexes. However, the authors have prioritized review of data obtained from female patients, and direct comparison of CMR between women and men. This position statement does not consider CMR accessibility or availability of local expertise, but instead highlights the optimal utilization of CMR in women with known or suspected cardiovascular disease. Finally, the ultimate goal of this position statement is to improve the health of female patients with cardiovascular disease by providing specific recommendations on the use of CMR.

中文翻译：

---

患有心血管疾病的女性的心血管磁共振：心血管磁共振协会 (SCMR) 的立场声明


本文件是心血管磁共振协会 (SCMR) 关于心血管磁共振 (CMR) 临床应用在患有心血管疾病的女性中的建议的立场声明。该文件由 SCMR 女性心血管疾病患者 CMR 成像共识小组编写，并得到 SCMR 出版委员会和 SCMR 执行委员会的认可。本文件的目标是 (1) 指导心血管成像方法的明智选择，(2) 为临床决策提供信息，(3) 教育利益相关者了解 CMR 在特定临床情况下的优势，以及 (4) 使患者能够参与其临床护理的临床证据。当前文件中提出的临床实用性声明涉及以下临床情况：急性冠脉综合征、稳定型缺血性心脏病、围产期心肌病、癌症治疗相关的心功能不全、妊娠期主动脉综合征和先天性心脏病、二尖瓣主动脉瓣和主动脉病、系统性风湿病和胶原血管疾病，以及引起心肌病的突变。作者引用了已发表的可用证据，否则提供了专家共识。大多数现有证据都涉及涉及男女受试者的转化研究。然而，作者优先审查从女性患者获得的数据，并直接比较女性和男性之间的 CMR。本立场声明并未考虑 CMR 的可及性或当地专业知识的可用性，而是强调了 CMR 在已知或疑似心血管疾病的女性中的最佳利用。 最后，本立场声明的最终目标是通过提供 CMR 使用的具体建议来改善女性心血管疾病患者的健康。